112 related articles for article (PubMed ID: 11216910)
21. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens.
Hsieh CL; Pang VF; Chen DS; Hwang LH
Hum Gene Ther; 1997 Nov; 8(16):1843-54. PubMed ID: 9382951
[TBL] [Abstract][Full Text] [Related]
22. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
Ju DW; Cao X; Acres B
J Cancer Res Clin Oncol; 1996; 122(12):716-22. PubMed ID: 8954168
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2.
Kudo-Saito C; Wansley EK; Gruys ME; Wiltrout R; Schlom J; Hodge JW
Clin Cancer Res; 2007 Mar; 13(6):1936-46. PubMed ID: 17363550
[TBL] [Abstract][Full Text] [Related]
24. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
[TBL] [Abstract][Full Text] [Related]
25. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
[TBL] [Abstract][Full Text] [Related]
26. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity.
Ju DW; Wang BM; Cao X
J Cancer Res Clin Oncol; 1998; 124(12):683-9. PubMed ID: 9879829
[TBL] [Abstract][Full Text] [Related]
28. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.
Li Q; Pan PY; Gu P; Xu D; Chen SH
Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
Day KV; Li D; Liu S; Guo M; O'Malley BW
Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
[TBL] [Abstract][Full Text] [Related]
30. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S
Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207
[TBL] [Abstract][Full Text] [Related]
31. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
[TBL] [Abstract][Full Text] [Related]
32. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Sugaya M; Asano T; Ochiai T; Isono K; Horitsu K; Kageyama H; Nakamura Y; Sakiyama S
Cancer Lett; 1996 Mar; 101(2):257-61. PubMed ID: 8620478
[TBL] [Abstract][Full Text] [Related]
34. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
35. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
36. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
Bernt KM; Ni S; Tieu AT; Lieber A
Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
[TBL] [Abstract][Full Text] [Related]
37. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.
Thomas MC; Greten TF; Pardoll DM; Jaffee EM
Hum Gene Ther; 1998 Apr; 9(6):835-43. PubMed ID: 9581906
[TBL] [Abstract][Full Text] [Related]
38. Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice.
Burger JA; Baird SM; Powell HC; Sharma S; Eling DJ; Kipps TJ
Br J Haematol; 2000 Mar; 108(3):641-52. PubMed ID: 10759724
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM‑CSF and IL‑12, enhance the anti‑renal cortical adenocarcinoma effect.
Xu HY; Li N; Yao N; Xu XF; Wang HX; Liu XY; Zhang Y
Oncol Rep; 2019 Aug; 42(2):866-879. PubMed ID: 31233203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
